Literature DB >> 6417217

Hypothalamic-pituitary-thyroid axis in acromegaly.

E Carmina, F Rosato, S Pirronello, A Jannì.   

Abstract

To evaluate the hypothalamic-pituitary-thyroid axis in acromegaly, total and free thyroid hormones and TSH response to TRH were determined in 36 acromegalic patients. In 10 patients, rT3 and thyroxine binding globulin (TBG) were also assayed by radioimmunoassay. In 15 patients the TSH response to TRH was also studied after medical or surgical therapy of the acromegaly. In 34 patients total thyroid hormones were in the normal range whereas two patients had low serum levels of free thyroid hormones. Thirty-two of the acromegalic patients were euthyroid. However, only 43.7% of the euthyroid patients had a normal TSH response to TRH. Nine patients had a reduced TSH rise after TRH, whereas in 4 patients the response was exaggerated and 5 delayed. In all patients studied rT3 and TBG were in the normal range. After medical or surgical therapy of the acromegaly we observed improvement or normalization of the TSH response to TRH. In conclusion, the TSH response to TRH is frequently altered in acromegaly, whereas thyroid function is generally normal. Hypothalamic effects of GH hyperproduction may explain the alterations of TSH secretion in many cases in view of the normalization of TSH secretion after therapy of acromegaly.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6417217     DOI: 10.1007/BF03347587

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  15 in total

1.  Thyroxine turnover and transport in active acromegaly.

Authors:  M Inada; K Sterling
Journal:  J Clin Endocrinol Metab       Date:  1967-07       Impact factor: 5.958

2.  Thyroid function in acromegaly.

Authors:  E Mukhtar; L Alexander; R Wilkinson; D Appleton; R Hall
Journal:  Lancet       Date:  1971-08-07       Impact factor: 79.321

Review 3.  Neuroendocrine control of thyrotropin secretion.

Authors:  J E Morley
Journal:  Endocr Rev       Date:  1981       Impact factor: 19.871

Review 4.  Clinical effects and uses of hypothalamic releasing and inhibiting factors.

Authors:  C Gual
Journal:  Front Neuroendocrinol       Date:  1973       Impact factor: 8.606

5.  Increase of serum growth hormone concentration following thyrotropin-releasing hormone injection in patients with acromegaly or gigantism.

Authors:  M Irie; T Tsushima
Journal:  J Clin Endocrinol Metab       Date:  1972-07       Impact factor: 5.958

6.  Modification of the actions of some neuroactive drugs by growth hormone.

Authors:  L C Tang; G C Cotzias
Journal:  Arch Neurol       Date:  1976-02

7.  Thyrotropin secretion in patients with central hypothyroidism: evidence for reduced biological activity of immunoreactive thyrotropin.

Authors:  G Faglia; L Bitensky; A Pinchera; C Ferrari; A Paracchi; P Beck-Peccoz; B Ambrosi; A Spada
Journal:  J Clin Endocrinol Metab       Date:  1979-06       Impact factor: 5.958

8.  Thyroid function in acromegaly before and after transsphenoidal hypophysectomy followed by cryoapplication.

Authors:  B A Lamberg; R Pelkonen; A Aro; B Grahne
Journal:  Acta Endocrinol (Copenh)       Date:  1976-06

9.  Elevated plasma TSH and hypothyroidism in children with hypothalamic hypopituitarism.

Authors:  R Illig; H Krawczyńska; T Torresani; A Prader
Journal:  J Clin Endocrinol Metab       Date:  1975-10       Impact factor: 5.958

10.  Parameters of thyroid function in patients with active acromegaly.

Authors:  D F Corrigan; L Wartofsky; R C Dimond; M Schaaf; J M Earll; J E Rogers; F D Wright; K D Burman
Journal:  Metabolism       Date:  1978-02       Impact factor: 8.694

View more
  3 in total

1.  Thyroid volume and function in patients with acromegaly living in iodine deficient areas.

Authors:  R Junik; J Sawicka; W Kozak; M Gembicki
Journal:  J Endocrinol Invest       Date:  1997-03       Impact factor: 4.256

2.  Thyroid autoimmune disorders in patients with acromegaly.

Authors:  M Manavela; C Vigovich; K Danilowicz; A Juri; L Miechi; V Fernandez Valoni; O D Bruno
Journal:  Pituitary       Date:  2015-12       Impact factor: 4.107

3.  The influence of diabetes mellitus on thyrotropin response to thyrotropin-releasing hormone in untreated acromegalic patients.

Authors:  C Shigemasa; K Abe; S Taniguchi; Y Mitani; Y Ueta; T Adachi; K Urabe; T Tanaka; A Yoshida; T Hori
Journal:  J Endocrinol Invest       Date:  1988-04       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.